BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30462329)

  • 1. Fasudil, a Rho-Associated Coiled Coil-Forming Protein Kinase Inhibitor, Recovers Methylmercury-Induced Axonal Degeneration by Changing Microglial Phenotype in Rats.
    Fujimura M; Usuki F; Nakamura A
    Toxicol Sci; 2019 Mar; 168(1):126-136. PubMed ID: 30462329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Rho/ROCK pathway prevents neuronal degeneration in vitro and in vivo following methylmercury exposure.
    Fujimura M; Usuki F; Kawamura M; Izumo S
    Toxicol Appl Pharmacol; 2011 Jan; 250(1):1-9. PubMed ID: 20869980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice.
    Ding J; Li QY; Wang X; Sun CH; Lu CZ; Xiao BG
    J Neurochem; 2010 Sep; 114(6):1619-29. PubMed ID: 20882700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway.
    Chen J; Sun Z; Jin M; Tu Y; Wang S; Yang X; Chen Q; Zhang X; Han Y; Pi R
    J Neuroimmunol; 2017 Apr; 305():108-114. PubMed ID: 28284330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.
    Tönges L; Günther R; Suhr M; Jansen J; Balck A; Saal KA; Barski E; Nientied T; Götz AA; Koch JC; Mueller BK; Weishaupt JH; Sereda MW; Hanisch UK; Bähr M; Lingor P
    Glia; 2014 Feb; 62(2):217-32. PubMed ID: 24311453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
    Hofni A; Shehata Messiha BA; Mangoura SA
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
    Xueyang D; Zhanqiang M; Chunhua M; Kun H
    Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROCK inhibition with fasudil promotes early functional recovery of spinal cord injury in rats by enhancing microglia phagocytosis.
    Fu PC; Tang RH; Wan Y; Xie MJ; Wang W; Luo X; Yu ZY
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):31-36. PubMed ID: 26838736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
    Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
    McGown CC; Brown NJ; Hellewell PG; Brookes ZL
    Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs.
    Suzuki K; Nemoto K; Ninomiya N; Kuno M; Kubota M; Yokota H
    J Surg Res; 2012 Nov; 178(1):352-7. PubMed ID: 22487385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats.
    Song H; Gao D
    Int J Mol Med; 2011 Aug; 28(2):193-8. PubMed ID: 21455561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.